SPECTRUM PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q3 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Spectrum Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $30K, a 11.1% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $46K, a 1050% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $4K.
  • Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was -$60K, a 99.3% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $30K $0 -$16K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $46K $1K +$6K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $40K $16K +$16K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $24K $13K -$3K -18.8% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $27K $16K +$23K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4K -$5K +$70K +93.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$66K $0 -$6K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$60K $16K +$7K +77.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$67K -$7K -$7K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$60K -$75K +$505K +87.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$565K $6K +$206K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$771K $9K +$221K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$992K $0 +$8.22M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$9.21M -$580K +$482K +45.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$9.69M -$200K -$58K -40.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$9.63M -$212K -$582K -157% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$9.05M -$8.22M -$7.15M -670% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$1.9M -$1.06M +$19.5M +94.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$21.4M -$142K +$1.32M +90.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$22.7M $370K +$115K +45.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$22.8M -$1.07M -$866K -431% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$21.9M -$20.5M -$18.9M -1124% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$3.09M -$1.47M -$1M -216% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.09M $255K +$361K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$2.45M -$201K -$135K -205% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$2.31M -$1.68M -$2.05M -554% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$267K -$464K -$386K -495% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $119K -$106K -$83K -361% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $202K -$66K -$204K -148% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $406K $369K +$437K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$31K -$78K -$3.56M -102% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $3.52M -$23K +$1.28M +98.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.25M $138K +$60K +76.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $2.19M -$68K -$35.6M -100% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $37.8M $3.48M +$8.21M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $29.6M -$1.3M +$1.67M +56.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $27.9M $78K +$2.42M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $25.5M $35.5M +$31.4M +753% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$5.88M -$4.73M -$6.61M -352% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $734K -$2.97M -$5.96M -200% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $6.69M -$2.34M +$21M +90% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$14.3M $4.17M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $1.88M +$1.23M +189% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 $2.99M +$1.34M +80.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$23.3M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $650K +$729K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $1.65M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q3 2010 -$79K Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.